SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13: 73944.
  • 2
    Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982; 1: 4769.
  • 3
    Meikle AW, Stannish WM. Familial prostatic cancer risk and low testosterone. J Clin Endocrinol Metab 1982; 54: 11048.
  • 4
    Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 13714.
  • 5
    Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanche H, Bellane-Chantelot C, et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998; 62: 141624.
  • 6
    Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 1759.
  • 7
    Gibbs M, Stanford JL, McIndoe RA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999; 64: 77687.
  • 8
    Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN, Schaid DJ. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000; 67: 8291.
  • 9
    Xu J, Zheng SL, Chang B, Smith JR, Carpten JD, Stine OC, Isaacs SD, Wiley KE, Henning L, Ewing C, Bujnovszky P, Bleeker ER, et al. Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet 2001; 108: 33545.
  • 10
    Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, et al. A candidate susceptibility gene at chromosome17p. Nat Genet 2001; 27: 17280.
  • 11
    Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002; 32: 5813.
  • 12
    Rennert H, Bercovich D, Hubert A, Abeliovich D, Rozovsky U, BarShira A, Soloviov S, Schrieber L, Matzkin H, Rennert G, Kadouri L, Peretz T, et al. A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet 2002; 71: 9814.
  • 13
    Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, Ewing CM, Faith DA, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002; 32: 3215.
  • 14
    Ford D. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343: 6925.
  • 15
    Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardem-Jones A, et al. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003; 72: 112.
  • 16
    Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager Sl, Peterson BJ, Smith DI, Cheville JC, et al. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003; 72: 27080.
  • 17
    Narod S. Genetic epidemiology of prostate cancer. Biochim Biophys Acta 1998: F1–13.
  • 18
    Gronberg H, Wiklund F, Damber JE. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations. Cancer 1999; 86: 47783.
  • 19
    Wolf FM. Meta-analysis: quantitative methods for research synthesis. Beverly Hills: Sage, 1986.
  • 20
    Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Epidemiol 1991; 44: 12718.
  • 21
    Moher D, Cook D, Eastwood S, Olkin I, Rennie D, Stroup D. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet 1999; 354: 1896900.
  • 22
    Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. New York: Wiley, 2000.
  • 23
    Hayes RB, Life JM, Pottern LM, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Silverman DT, Morris Brown L, Hoover RN, Fraumeni Jr JF. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 3614.
  • 24
    Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 13057.
  • 25
    Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995; 141: 73240.
  • 26
    Glover FE Jr, Coffey DS, Douglas L, Russell H, Cadigan M, Tulloch T, Wedderburn k, Wan R, Baker TD, Walsh PC. Familial study of prostate cancer in Jamaica. Urology 1998; 52: 4413.
  • 27
    Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991; 19: 4352.
  • 28
    Bratt O, Kristoffersson U, Lundgren R, Olsson H. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. Eur J Cancer 1997; 33: 223740.
  • 29
    Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 1999; 35: 2727.
  • 30
    Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden: a nationwide register cohort study. Cancer 1996; 77: 13843.
  • 31
    Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995; 87: 9916.
  • 32
    Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 33747.
  • 33
    Kalish LA, McDougal WS, McKinlay JB. Family history and the risk of prostate cancer. Urology 2000; 56: 8036.
  • 34
    Pharoah P, Day N, Duffy S, Easton DF, Ponder B. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71: 8009.
  • 35
    Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996; 144: 10417.
  • 36
    Ihaka R, Gentleman R. A language for data analysis and graphics. J Comput Graph Stat 1996; 5: 299314.
  • 37
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall, 1993.
  • 38
    McCahy PJ, Harris CA, Neal DE. Breast and prostate cancer in the relatives of men with prostate cancer. Br J Urol 1996; 78: 5526.
  • 39
    Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. Br Med J 2001; 323: 1015.
  • 40
    Aprikian AG, Bazinet M, Plante M, Meshref A, Trudel C, Aronson S, Nachabe M, Peloquin F, Dessureault J, Narod S, Begin L, Elhilali M. Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J Urol 1995; 154: 4046.
  • 41
    Rodriguez C, Calle EE, Tatham LM, Wingo PA, Miracle-McMahill HL, Thun MJ, Heath CW Jr.. Family history of breast cancer as a predictor for fatal prostate cancer. Epidemiology 1998; 9: 5259.
  • 42
    Schuurman AG, Zeegers MPA, Goldbohm RA, Van Den Brandt PA. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology 1999; 10: 1925.
  • 43
    Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multi-center case control study in Canada. Int J Cancer 1997; 70: 67981.
  • 44
    Lightfoot N, Kreigr N, Sass-Kortsak A, Purdham J, Buchan G. Prostate cancer risk. Medical history, sexual, and hormonal factors [Abstract]. Ann Epidemiol 2000; 10: 470.
  • 45
    Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999; 8: 5360.
  • 46
    Goldgar DE, Easton DF, Cannon-Albright L, Skolnick M. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 16008.
  • 47
    Narod SA, Dupont A, Cusan L, Diamond P, Gomez JL, Suburu R, Labrie F. The impact of family history on early detection of prostate cancer. Nat Med 1995; 1: 99101.
  • 48
    Keetch DW, Rice JP, Saurez BK, Catalona W. Familial aspects of prostate cancer: a case-control study. J Urol 1995; 154: 21003.
  • 49
    Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO. Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 1996; 5: 50913.
  • 50
    Dong C. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 2001; 92: 14450.
  • 51
    Cui J, Staples MP, Hopper JL, English DR, Mccredie MR, Giles GG. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001; 68: 120718.
  • 52
    Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002; 13: 47182.
  • 53
    Simard J, Dumont M, Soucy P, Labrie F. Perspective: prostate cancer susceptibility genes. Endocrinology 2002; 143: 202940.
  • 54
    Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 55763.
  • 55
    Rodriguez C, Calle EE, Miracle-McMahill HL, Tatham LM, Wingo PA, Thun MJ, Heath Jr CW. Family history and risk of fatal prostate cancer. Epidemiology 1997; 8: 6537.